-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
LENZ Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2020 to 2023.
- LENZ Therapeutics, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$12.9M, a 34.8% increase year-over-year.
- LENZ Therapeutics, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$131M, a 76.8% decline year-over-year.
- LENZ Therapeutics, Inc. annual Operating Income (Loss) for 2023 was -$135M, a 28% decline from 2022.
- LENZ Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$106M, a 74.8% decline from 2021.
- LENZ Therapeutics, Inc. annual Operating Income (Loss) for 2021 was -$60.4M, a 348% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)